Skip to main content
. 2018 Sep 30;27(3):166–174. doi: 10.7570/jomes.2018.27.3.166

Table 4.

The clustering effects of metabolic factors in metabolic syndrome

No. of metabolic factors Abnormal metabolic factor Male Female



WC HP Glu TG HDL-C Frequency (observed/expected) O/E 95% CI Frequency (observed/expected) O/E 95% CI
1 + 3.8/5.9 0.65 0.51–0.82 8.4/12.2 0.69 0.58–0.82
+ 9.0/10.1 0.89 0.77–1.03 4.9/7.6 0.65 0.53–0.79
+ 2.0/3.9 0.50 0.36–0.70 0.8/3.0 0.28 0.18–0.42
+ 8.2/13.0 0.63 0.52–0.77 2.1/6.7 0.31 0.24–0.40
+ 2.7/4.0 0.68 0.48–0.95 8.0/9.7 0.82 0.71–0.94

2 + + 2.3/3.7 0.64 0.47–0.87 3.6/4.4 0.81 0.64–1.01
+ + 0.6/1.4 0.40 0.21–0.75 0.9/1.7 0.50 0.33–0.78
+ + 3.6/4.7 0.76 0.56–1.01 1.9/3.9 0.50 0.35–0.69
+ + 0.6/1.5 0.41 0.23–0.75 4.6/5.7 0.81 0.66–1.00
+ + 1.7/2.4 0.69 0.51–0.94 0.7/1.1 0.64 0.40–1.04
+ + 6.0/8.1 0.74 0.62–0.89 1.6/2.5 0.66 0.47–0.93
+ + 0.9/2.5 0.35 0.20–0.61 1.4/3.6 0.38 0.26–0.56
+ + 2.1/3.1 0.68 0.49–0.94 0.2/1.0 0.17 0.05–0.59
+ + 0.4/1.0 0.37 0.18–0.79 0.4/1.4 0.31 0.17–0.56
+ + 4.0/3.2 1.24 0.97–1.60 2.6/3.1 0.83 0.63–1.10

3 + + + 1.2/0.9 1.34 0.84–2.15 0.9/0.6 1.40 0.90–2.17
+ + + 4.4/2.9 1.49 1.17–1.88 2.4/1.4 1.66 1.29–2.14
+ + + 0.5/0.9 0.57 0.30–1.09 1.7/2.1 0.81 0.62–1.06
+ + + 1.2/1.1 1.04 0.69–1.56 0.6/0.6 1.01 0.58–1.78
+ + + 0.4/0.3 1.10 0.46–2.62 0.7/0.8 0.85 0.49–1.49
+ + + 1.6/1.2 1.40 1.00–1.94 3.2/1.8 1.73 1.37–2.19
+ + + 3.2/1.9 1.62 1.22–2.16 0.5/0.4 1.33 0.79–2.23
+ + + 0.3/0.6 0.42 0.21–0.83 0.5/0.5 0.93 0.47–1.84
+ + + 2.0/2.0 1.01 0.71–1.43 1.1/1.1 0.99 0.71–1.37
+ + + 1.1/0.8 1.41 0.90–2.21 0.3/0.4 0.72 0.37–1.39

4 + + + + 2.1/0.7 3.01 2.21–4.09 1.3/0.2 6.28 4.76–8.27
+ + + + 0.4/0.2 1.86 0.88–3.91 0.8/0.3 2.68 1.88–3.82
+ + + + 2.1/0.7 2.86 2.04–3.99 2.6/0.7 3.85 3.03–4.90
+ + + + 0.6/0.3 2.12 1.22–3.67 1.1/0.3 4.37 3.04–6.27
+ + + + 1.0/0.5 2.11 1.35–3.30 0.7/0.2 4.19 2.49–7.06

5 + + + + + 1.3/0.2 7.36 5.27–10.25 2.2/0.1 22.83 17.69–29.42

WC, waist circumference; HP, hypertension; Glu, hyperglycemia; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; O/E, ratio of observed prevalence to expected prevalence; CI, confidence interval.